Exact Mass: 572.3362

Exact Mass Matches: 572.3362

Found 5 metabolites which its exact mass value is equals to given mass value 572.3362, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Chemistry 2

5-benzyl-4-(cyclohexylmethyl)-1-{4-[5,6-dioxo-1-(2-phenylethyl)piperazin-2-yl]butyl}piperazine-2,3-dione

C34H44N4O4 (572.3362)


   

Tazemetostat

N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-4-methyl-4-[(morpholin-4-yl)methyl]-[1,1-biphenyl]-3-carboxamide

C34H44N4O4 (572.3362)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

4,5-Secopyrophaeophorbide a

4,5-Secopyrophaeophorbide a

C34H44N4O4 (572.3362)


   

Tazemetostat

Tazemetostat (EPZ-6438)

C34H44N4O4 (572.3362)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS